Year: 2015
Type: article
Abstract: What’s a good fragment? Fragment-based drug discovery is well-established within many pharmaceutical, biotech, and academic institutions for generating new drugs. In this Essay, the opportunities and challenges for organic chemists to design and synthesize new fragments are described.
Authors: Christopher W. Murray, David C. Rees
Institution: Astex Pharmaceuticals
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $5,510
Funder: Astex Pharmaceuticals
OpenAlex ID: W1944091105
